Vertex Pharmaceuticals Profit Margin

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:3em;padding-top: 35px;;'>VRT</div>
VRTX -- USA Stock  

 Earnings Call  This Week

Vertex Pharmaceuticals profit-margin fundamental analysis lookup allows you to check this and other indicators for Vertex Pharmaceuticals Incorpor or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please continue to Equity Screeners to view more equity screening tools
Symbol
Refresh

Vertex Pharmaceuticals Profit Margin Analysis

Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
 2017 2018 2019 2020 (projected)
Receivables310.25 M414.87 M373.38 M402.86 M
Inventories111.83 M124.36 M111.92 M120.76 M
Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company was founded in 1989 and is headquartered in Boston, Massachusetts. Vertex Pharmaceuticals operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 2500 people.
ReceivablesInventories
Profit Margin 
 = 
Net Income 
Revenue 
X
100 
More About Profit Margin | All Equity Analysis
Vertex Pharmaceuticals Profit Margin  =
0.0031 
ValuationFundamentalsBuy or Sell

Vertex Pharmaceuticals Profit Margin Over Time Pattern

 Vertex Pharmaceuticals Profit Margin 
    
  Timeline 

About Profit Margin

In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Compare to competition

Vertex Pharmaceuticals Profit Margin Assessment

Operating Margin
Based on latest financial disclosure Vertex Pharmaceuticals Incorpor has Profit Margin of 0.0031%. This is 100.03% lower than that of the Healthcare sector, and 100.01% lower than that of Biotechnology industry, The Profit Margin for all stocks is 100.24% lower than the firm.

Did you try this?

Run Pair Correlation Now

   

Pair Correlation

Compare performance and examine historical correlation between any two equity instruments
All  Next Launch Module

Vertex Pharmaceuticals current financial ratios